AzurRx BioPharma Announces Positive Interim Data in Phase 2 Clinical Trial of MS1819 in Combination with PERT in the Treatment of Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

NEXT STORY
Medical Supply Delivery Service Market to hit US $96.11 Billion by 2028 – Global Insights on Latest Trends, Strategic Initiatives, Growth Drivers, COVID-19 Impact Analysis, Leading Players and Business Opportunities: Adroit Market Research
PREV STORY
Fennec Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CORRECTING AND REPLACING: Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update

ORLANDO, Fla., May 16, 2018 (GLOBE NEWSWIRE) -- In a release issued earlier today ...

author_avatar
NASDAQ Market News

BioSig’s PURE EP System to be Featured in a Live Patient Case During Annual International Symposium on Ventricular Arrhythmias

author_avatar
NASDAQ Market News

Acupath Laboratories Announces Expansion of COVID-19 Test Offerings With Introduction of Low-Cost Saliva PCR Assay

author_avatar
NASDAQ Market News